Full-Time

Specialist Software Engineer

Full Stack

Updated on 6/18/2025

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior

Hyderabad, Telangana, India

Category
Full-Stack Engineering
Software Engineering
Required Skills
Kubernetes
Microsoft Azure
FastAPI
Python
JavaScript
React.js
Node.js
Postgres
Docker
Microservices
AWS
REST APIs
Flask
AngularJS
Google Cloud Platform
Requirements
  • Bachelor’s degree in Computer Science, AI, Software Engineering, or related field.
  • 5+ years of experience in full-stack software engineering.
  • Proficiency with backend languages and frameworks (Python, FastAPI, Flask preferred).
  • Proficiency in JavaScript and modern web technologies, including React, Angular, and Node.js.
  • Experience with databases (Postgres/DynamoDB).
  • Experience managing and deploying infrastructure in at least one cloud provider such as AWS (preferred), Azure, or Google Cloud.
  • Experience with microservices architecture and containerization (Docker, Kubernetes).
Responsibilities
  • Design, develop, and maintain microservices to ensure the software is modular, scalable, and maintainable.
  • Create and manage RESTful APIs to facilitate seamless communication between different software components and external systems.
  • Apply and advocate for best practices in software development, including code reviews, unit testing, continuous integration, and continuous deployment.
  • Implement and manage deployments using Docker to ensure consistent and efficient application delivery across different environments.
  • Design, implement, and maintain database schemas, ensuring efficient data storage, retrieval, and manipulation.
  • Develop user-friendly and responsive front-end applications using modern web technologies to provide a seamless user experience.
  • Work closely with product managers, designers, and other engineers to deliver high-quality software solutions that meet business requirements.
  • Identify and resolve software issues and bugs promptly to ensure smooth operation and minimal downtime.
  • Stay updated with emerging technologies, industry trends, and best practices in software development to continuously improve skills and knowledge.
  • Promotes code quality through reviews, static analysis tools, and adherence to team standards and best practices.
  • Provide guidance and mentorship to junior engineers, fostering a collaborative and growth-oriented team environment.
Desired Qualifications
  • Familiarity with enterprise software systems in life sciences or healthcare domains.
  • Familiarity with big data platforms and experience in data pipeline development (Databricks, Spark).
  • Knowledge of data security, privacy regulations, and scalable software solutions.

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care by providing effective treatments for serious health conditions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Micromet boosts Amgen's oncology portfolio with BiTE antibody blinatumomab.
  • Institutional investments indicate strong confidence in Amgen's financial health and prospects.
  • Amgen's AI-driven drug discovery investments could accelerate R&D capabilities.

What critics are saying

  • Micromet acquisition may face clinical or regulatory challenges impacting strategic goals.
  • Investor pressure for short-term gains may affect long-term R&D investments.
  • FTC scrutiny on mergers could hinder Amgen's future strategic growth.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline in oncology, cardiovascular, and autoimmune disorders.
  • Amgen's strategic acquisitions enhance its innovative medicine portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

Amgen
Jun 2nd, 2025
Amgen to Acquire Micromet| Amgen

The acquisition includes blinatumomab, a Bispecific T cell Engager (BiTE) antibody in Phase 2 clinical development for acute lymphoblastic leukemia (ALL). Blinatumomab is also in clinical development for the treatment of non-Hodgkin's lymphoma (NHL), and could have applications in other hematologic malignancies.

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.